MINGYANG TECHNOLOGY
837663
Shanghai Weihong Electronic Technology
300508
Shenzhen Intellifusion Technologies
688343
4
Est Tools Co., Ltd.
300488
5
Jiangyin Pivot Automotive Products
301181
US Stock MarketDetailed Quotes
AIM AIM ImmunoTech
- 0.1225
- -0.0114-8.51%
Trading Feb 25 10:02 ET
8.42MMarket Cap-0.26P/E (TTM)
0.1341High0.1225Low275.28KVolume0.1260Open0.1339Pre Close34.67KTurnover0.47%Turnover RatioLossP/E (Static)68.75MShares0.620052wk High2.92P/B7.25MFloat Cap0.120252wk Low--Dividend TTM59.18MShs Float836.0000Historical High--Div YieldTTM8.66%Amplitude0.1202Historical Low0.1250Avg Price1Lot Size
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!
AIM ImmunoTech Stock Forum
extracted from X, NFA
Our lead program is an immuno-modulator that has shown positive data published in
numerous well-respected journals and forums. Learn more: bit.ly/4gzyqnz
AIM ImmunoTech Announces That It Will Not Proceed With an Offering Pursuant to Its Registration Statement on Form S-1 Until After It Files Its Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2024
4X Immune Response: AIM's Ampligen Breakthrough with AstraZeneca's FluMist Against Bird Flu
AIM ImmunoTech announces a planned follow-up clinical study evaluating a combination treatment of AIM's Ampligen® and AstraZeneca's FluMist® to address the recent avian influenza outbreaks
Friday, 7th February at 8:50 am
OCALA, Fla., Feb. 07, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE: AIM) ("AIM" or the "Company") today announced its initiation of a plan to advance Ampligen as a vaccine adjuvant for avian influenza as part of the Company's antiviral priorit...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, ...
AIM had news and didn't run which also happened with IVVD and CPIX. Both were held down, shorted and eventually ran. They ran the same day though so not sure about AIM but worth the watch!
$AIM ImmunoTech (AIM.US)$
I still have my eyes on KTTA - news was released today and it didn't really run. It got beaten down so could still see its day, or maybe not lol.
$Pasithea Therapeutics (KTTA.US)$
Remember, chasing is a dangerous game. Be very selective with...
No comment yet